Abner Herrman & Brock’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.05M | Sell |
8,418
-2,680
| -24% | -$917K | 0.29% | 46 |
|
|
2026
Q1 | $3.9M | Sell |
11,098
-234
| -2% | -$83.4K | 0.43% | 43 |
|
|
2025
Q4 | $3.71M | Sell |
11,332
-594
| -5% | -$188K | 0.38% | 45 |
|
|
2025
Q3 | $3.37M | Sell |
11,926
-154
| -1% | -$44.7K | 0.35% | 47 |
|
|
2025
Q2 | $3.37M | Buy |
12,080
+465
| +4% | +$132K | 0.38% | 45 |
|
|
2025
Q1 | $3.62M | Sell |
11,615
-11
| -0.1% | -$3.25K | 0.46% | 41 |
|
|
2024
Q4 | $3.03M | Buy |
11,626
+166
| +1% | +$49.3K | 0.38% | 43 |
|
|
2024
Q3 | $3.69M | Buy |
11,460
+297
| +3% | +$97.2K | 0.45% | 46 |
|
|
2024
Q2 | $3.49M | Buy |
11,163
+391
| +4% | +$115K | 0.44% | 47 |
|
|
2024
Q1 | $3.06M | Buy |
10,772
+815
| +8% | +$238K | 0.38% | 47 |
|
|
2023
Q4 | $2.87M | Buy |
9,957
+1,533
| +18% | +$418K | 0.4% | 48 |
|
|
2023
Q3 | $2.26M | Buy |
8,424
+2,485
| +42% | +$620K | 0.35% | 49 |
|
|
2023
Q2 | $1.32M | Buy |
5,939
+2,841
| +92% | +$659K | 0.19% | 50 |
|
|
2023
Q1 | $749K | Buy |
3,098
+2,158
| +230% | +$530K | 0.11% | 63 |
|
|
2022
Q4 | $247K | Sell |
940
-25
| -3% | -$6.7K | 0.04% | 88 |
|
|
2022
Q3 | $218K | Buy |
+965
| New | +$234K | 0.04% | 85 |
|
|
2021
Q3 | – | Sell |
-1,088
| Closed | -$265K | – | 101 |
|
|
2021
Q2 | $265K | Hold |
1,088
| – | – | 0.04% | 79 |
|
|
2021
Q1 | $271K | Sell |
1,088
-34
| -3% | -$8.11K | 0.04% | 80 |
|
|
2020
Q4 | $258K | Buy |
1,122
+45
| +4% | +$10.4K | 0.04% | 97 |
|
|
2020
Q3 | $274K | Sell |
1,077
-55
| -5% | -$13.6K | 0.05% | 83 |
|
|
2020
Q2 | $267K | Buy |
1,132
+6
| +0.5% | +$1.37K | 0.05% | 81 |
|
|
2020
Q1 | $228K | Sell |
1,126
-919
| -45% | -$201K | 0.05% | 83 |
|
|
2019
Q4 | $493K | Buy |
2,045
+175
| +9% | +$38.6K | 0.07% | 79 |
|
|
2019
Q3 | $362K | Sell |
1,870
-102
| -5% | -$19.6K | 0.05% | 84 |
|
|
2019
Q2 | $363K | Sell |
1,972
-1,115
| -36% | -$200K | 0.05% | 85 |
|
|
2019
Q1 | $586K | Sell |
3,087
-55,931
| -95% | -$10.7M | 0.09% | 69 |
|
|
2018
Q4 | $11.5M | Buy |
59,018
+2,505
| +4% | +$489K | 2.1% | 18 |
|
|
2018
Q3 | $11.7M | Buy |
56,513
+3,672
| +7% | +$724K | 1.67% | 24 |
|
|
2018
Q2 | $9.75M | Buy |
52,841
+802
| +2% | +$142K | 1.52% | 29 |
|
|
2018
Q1 | $8.87M | Buy |
52,039
+4,343
| +9% | +$797K | 1.41% | 31 |
|
|
2017
Q4 | $8.29M | Buy |
47,696
+3,299
| +7% | +$584K | 1.4% | 29 |
|
|
2017
Q3 | $8.28M | Buy |
44,397
+1,086
| +3% | +$192K | 1.47% | 29 |
|
|
2017
Q2 | $7.46M | Buy |
43,311
+1,869
| +5% | +$304K | 1.41% | 30 |
|
|
2017
Q1 | $6.8M | Buy |
41,442
+3,181
| +8% | +$529K | 1.35% | 33 |
|
|
2016
Q4 | $5.85M | Buy |
38,261
+3,774
| +11% | +$568K | 1.23% | 36 |
|
|
2016
Q3 | $5.75M | Buy |
34,487
+443
| +1% | +$74.9K | 1.31% | 36 |
|
|
2016
Q2 | $5.45M | Buy |
34,044
+2,908
| +9% | +$452K | 1.27% | 38 |
|
|
2016
Q1 | $4.67M | Buy |
31,136
+25,271
| +431% | +$3.75M | 1.17% | 39 |
|
|
2015
Q4 | $952K | Buy |
5,865
+85
| +1% | +$13.4K | 0.49% | 51 |
|
|
2015
Q3 | $856K | Buy |
5,780
+280
| +5% | +$44.1K | 0.46% | 49 |
|
|
2015
Q2 | $832K | Buy |
5,500
+235
| +4% | +$37.6K | 0.42% | 53 |
|
|
2015
Q1 | $842K | Sell |
5,265
-65
| -1% | -$10.2K | 0.43% | 54 |
|
|
2014
Q4 | $849K | Sell |
5,330
-12,141
| -69% | -$1.89M | 0.43% | 49 |
|
|
2014
Q3 | $2.45M | Sell |
17,471
-575
| -3% | -$75.1K | 0.72% | 51 |
|
|
2014
Q2 | $2.14M | Buy |
18,046
+3,185
| +21% | +$369K | 0.64% | 51 |
|
|
2014
Q1 | $1.83M | Hold |
14,861
| – | – | 0.59% | 51 |
|
|
2013
Q4 | $1.69M | Buy |
14,861
+10,816
| +267% | +$1.23M | 0.6% | 50 |
|
|
2013
Q3 | $453K | Sell |
4,045
-9,205
| -69% | -$998K | 0.3% | 67 |
|
|
2013
Q2 | $1.31M | Buy |
+13,250
| New | +$1.37M | 0.55% | 56 |
|
Other funds holding AMGN
FFM
SP
Abner Herrman & Brock's AMGN Position: Q2 2026 in Review
Abner Herrman & Brock reduced its Amgen (AMGN) stake by 24% in Q2 2026, selling an estimated $917K and leaving 8,418 shares worth $3.05M. The position accounts for 0.29% of the portfolio, ranked #46.
Abner Herrman & Brock first reported a position in AMGN in Q2 2013 and has held it in 49 quarters since. The position peaked at $11.7M in Q3 2018. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Abner Herrman & Brock held 8,418 shares of Amgen worth $3.05M as of Q2 2026.
- Abner Herrman & Brock sold 2,680 Amgen shares in Q2 2026, an estimated $917K.
- Amgen made up 0.29% of Abner Herrman & Brock's portfolio in Q2 2026, its #46 holding.
- Abner Herrman & Brock first reported a position in Amgen in Q2 2013 and has held it in 49 quarters since.
- Abner Herrman & Brock's Amgen position peaked at $11.7M in Q3 2018.
- 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Abner Herrman & Brock's 13F filing for Q2 2026, filed 8 Jul 2026.